Fig. 3.

Kaplan–Meier survival plot. Cumulative proportion of patients remaining relapse-free during continuation trial (phase 2). Log-rank test compared time-to-relapse for riluzole and placebo groups (${\chi }_1^2=0.17$, p = 0.68.).